PA
SYF icon

PharVision Advisers’s Synchrony SYF Stock Holding History

PharVision Advisers’s Portfolio SYF Stock Details SYF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,585
Closed -$255K – 992
2025
Q3 		$255K Buy
+3,585
New +$260K 0.14% 321
2025
Q1 		– Sell
-3,253
Closed -$211K – 501
2024
Q4 		$211K Buy
+3,253
New +$199K 0.18% 277

Other funds holding SYF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's SYF Position: Q4 2025 in Review

PharVision Advisers sold out of Synchrony (SYF) in Q4 2025, closing a stake of 3,585 shares — an estimated $255K sold.

PharVision Advisers first reported a position in SYF in Q4 2024 and held it in 2 quarters. The position peaked at $255K in Q3 2025. 997 funds tracked by Wall St. Rank hold SYF as of Q4 2025.

  • PharVision Advisers reported no remaining Synchrony position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,585 Synchrony shares in Q4 2025, an estimated $255K.
  • PharVision Advisers first reported a position in Synchrony in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Synchrony position peaked at $255K in Q3 2025.
  • 997 funds tracked by Wall St. Rank held Synchrony as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.